Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows

Fenwick, M A and Fitzpatrick, R and Kenny, D A and Diskin, M G and Patton, J and Murphy, J J and Wathes, D C (2008) Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. DOMESTIC ANIMAL ENDOCRINOLOGY, 34 (1). pp. 31-44.

[img] Text
1449.pdf
Restricted to Repository staff only

Download (302kB)

Abstract

In dairy cows, negative energy balance (NEB) during the early post-partum period is associated with major alterations in the growth hormone-insulin-like growth factor (GH-IGF) axis. Since the liver mediates nutrient partitioning during lactation, we aimed to determine how NEB alters the endocrine regulation of the insulin-like growth factor (IGF) system by investigating the expression of IGF family members and related steroid receptors. On the second day of lactation, cows were allocated to one of two treatments designed to produce mild (MNEB) or severe NEB (SNEB). MNEB cows (n = 5) were fed ad lib grass silage supplemented with concentrate and milked x I daily and SNEB cows (n = 6) were restricted in dietary intake and milked x3 daily. Energy balance (EB) status was monitored until the second week of lactation when plasma and liver samples revealed a markedly divergent metabolic profile. At this time, plasma protein and hepatic mRNA for IGF-I was reduced in SNEB cows compared with MNEB cows. Both levels of expression correlated highly when data from all animals was pooled (r=0.963; P < 0.01). SNEB cows also exhibited reduced hepatic expression for transcripts encoding IGF-1R, IGF-2R, IGF binding proteins (IGFBPs) -3, -4, -5, -6, acid labile subunit, and receptors for oestrogen (ER alpha) and growth hormone (total GHR and 1A variant), while the expression of IGFBP-2 was elevated. Expression of mRNA for IGF-II, IGFBP-1 and receptors for insulin (A/B) and glucocorticoid (a) was unaffected by EB. Results demonstrate that SNEB affects hepatic synthesis of IGF-I, and other components known to modulate the bioavailability and stability of circulating IGF-I. (c) 2006 Elsevier Inc. All rights reserved.